Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
$5.44
-0.4500 ( -7.64% ) 558.4K
BiondVax Pharmaceuticals Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline.
Market Data
Open
$5.44
Previous close
$5.89
Volume
558.4K
Market cap
$4.66M
Day range
$4.95 - $5.80
52 week range
$2.23 - $13.70
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Dec 14, 2023 |
6-k | Quarterly Reports | 2 | Nov 20, 2023 |
6-k | Quarterly Reports | 1 | Nov 13, 2023 |
6-k | Quarterly Reports | 2 | Nov 07, 2023 |
6-k | Quarterly Reports | 2 | Nov 03, 2023 |
6-k | Quarterly Reports | 2 | Nov 02, 2023 |
6-k | Quarterly Reports | 41 | Sep 22, 2023 |
6-k | Quarterly Reports | 2 | Sep 20, 2023 |
6-k | Quarterly Reports | 12 | Sep 19, 2023 |
6-k | Quarterly Reports | 30 | Sep 11, 2023 |